CIC
ZYME icon

Cornercap Investment Counsel’s Zymeworks ZYME Stock Holding History

Cornercap Investment Counsel’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-25,709
Closed -$270K – 706
2024
Q1 		$270K Hold
25,709
– – 0.04% 526
2023
Q4 		$267K Sell
25,709
-46
-0.2% -$367 0.04% 496
2023
Q3 		$163K Buy
+25,755
New +$190K 0.03% 504

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Cornercap Investment Counsel's ZYME Position: Q2 2024 in Review

Cornercap Investment Counsel sold out of Zymeworks (ZYME) in Q2 2024, closing a stake of 25,709 shares — an estimated $270K sold.

Cornercap Investment Counsel first reported a position in ZYME in Q3 2023 and held it in 3 quarters. The position peaked at $270K in Q1 2024. 164 funds tracked by Wall St. Rank hold ZYME as of Q2 2024.

  • Cornercap Investment Counsel reported no remaining Zymeworks position as of Q2 2024 after selling out during the quarter.
  • Cornercap Investment Counsel sold 25,709 Zymeworks shares in Q2 2024, an estimated $270K.
  • Cornercap Investment Counsel first reported a position in Zymeworks in Q3 2023 and held it in 3 quarters.
  • Cornercap Investment Counsel's Zymeworks position peaked at $270K in Q1 2024.
  • 164 funds tracked by Wall St. Rank held Zymeworks as of Q2 2024.

Based on Cornercap Investment Counsel's 13F filing for Q2 2024, filed 8 Aug 2024.